Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls-Reference-Cited by-同舟云学术

Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls

Published:2015-10-15 Issue:10 Volume:10 Page:e0139950
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Czech Christian,Tang Wakana,Bugawan Teodorica,Mano Calvin,Horn Carsten,Iglesias Victor Alejandro,Fröhner Stefanie,Zaworski Phillip G.,Paushkin Sergey,Chen Karen,Kremer Thomas

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference17 articles.

1. Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2–13.3;LM Brzustowicz;Nature,1990

2. Neurodegeneration in spinal muscular atrophy: from disease phenotype and animal models to therapeutic strategies and beyond;UR Monani;Future Neurol,2014

3. Identification and characterization of a spinal muscular atrophy-determining gene;S Lefebvre;Cell,1995

4. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2;UR Monani;Hum Mol Genet,1999

5. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy;CL Lorson;Proc Natl Acad Sci U S A,1999

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into spinal muscular atrophy from molecular biomarkers;Neural Regeneration Research;2024-06-26

2. The Importance of Early Treatment of Inherited Neuromuscular Conditions;Journal of Neuromuscular Diseases;2024-03-05

3. Neuromuscular disorders in the omics era;Clinica Chimica Acta;2024-01

4. Role of circulating biomarkers in spinal muscular atrophy: insights from a new treatment era;Frontiers in Neurology;2023-11-13

5. Molecular markers of disease severity and response to nusinersen therapy in 5q spinal muscular atrophy (literature review);Neuromuscular Diseases;2023-10-30